GlassScriptPhysician profile
James David Cowart
NPI 1578507877
$731.05
in general payments reported to CMS, 2019-2025
22 companies · $70.80 in 2025
The $70.80 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $156 · 2023: $96.54 · 2024: $128 · 2025: $70.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $233.74 | 2019-2020 | |
| Pfizer INC. | $68.63 | 2019-2023 | |
| Therapeuticsmd, INC. | $43.46 | 2019-2020 | |
| Astellas Pharma US INC | $42.23 | 2019-2023 | Veozah |
| Optumhealth Care Solutions, LLC | $30.98 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Hologic Sales and Service, LLC | $30.75 | 2023-2024 | Myosure Tissue Removal Device, Fluent Fluid Management System |
| Sage Therapeutics, LLC | $26.33 | 2024 | |
| Medtronic, INC. | $24.01 | 2023 | Ligasure |
| Mayne Pharma Commercial LLC | $22.73 | 2024 | |
| Amag Pharmaceuticals, INC. | $22.71 | 2019 | |
| Baxter Healthcare | $20.65 | 2025 | |
| Hydrofera LLC | $19.17 | 2025 | Hydrofera Blue |
| Smith+Nephew, INC. | $19.16 | 2024 | Pico |
| Sumitomo Pharma America, INC. | $17.62 | 2023 | Myfembree |
| Shield Therapeutics INC | $15.95 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $14.93 | 2024 | Cologuard Collection Kit |
| Organon LLC | $14.17 | 2024 | |
| Millicent US INC | $13.93 | 2019 | |
| Daiichi Sankyo INC. | $13.08 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.98 | 2019 | |
| Merck Sharp & Dohme LLC | $12.29 | 2020 | |
| Coopersurgical, INC. | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cowart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.